Novan Inc

NASDAQ:NOVN   1:00:00 PM EDT
0.82
-0.02 (-2.55%)
4:31:48 PM EDT: $0.85 +0.03 (+3.13%)
Earnings Announcements

Novan Reports Q3 2022 Financial Results

Published: 11/14/2022 13:29 GMT
Novan Inc (NOVN) - Novan Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Continued Progress Toward Submission of Berdazimer Gel, 10.3% (sb206) New Drug Application (nda), Targeted Around End of 2022.
Qtrly Loss per Share $0.25.
Q3 Earnings per Share View $-0.39 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $6.15 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $6.63 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.